229 related articles for article (PubMed ID: 22310283)
21. Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages.
Palii CG; Perez-Iratxeta C; Yao Z; Cao Y; Dai F; Davison J; Atkins H; Allan D; Dilworth FJ; Gentleman R; Tapscott SJ; Brand M
EMBO J; 2011 Feb; 30(3):494-509. PubMed ID: 21179004
[TBL] [Abstract][Full Text] [Related]
22. Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.
Cai Y; Xu Z; Xie J; Ham AJ; Koury MJ; Hiebert SW; Brandt SJ
Biochem Biophys Res Commun; 2009 Dec; 390(2):295-301. PubMed ID: 19799863
[TBL] [Abstract][Full Text] [Related]
23. Ubiquitination and degradation of Tal1/SCL are induced by notch signaling and depend on Skp2 and CHIP.
Nie L; Wu H; Sun XH
J Biol Chem; 2008 Jan; 283(2):684-92. PubMed ID: 17962192
[TBL] [Abstract][Full Text] [Related]
24. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
Sanda T; Leong WZ
Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
[TBL] [Abstract][Full Text] [Related]
25. mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor.
Huang S; Brandt SJ
Mol Cell Biol; 2000 Mar; 20(6):2248-59. PubMed ID: 10688671
[TBL] [Abstract][Full Text] [Related]
26. Chromatin looping defines expression of TAL1, its flanking genes, and regulation in T-ALL.
Zhou Y; Kurukuti S; Saffrey P; Vukovic M; Michie AM; Strogantsev R; West AG; Vetrie D
Blood; 2013 Dec; 122(26):4199-209. PubMed ID: 24200685
[TBL] [Abstract][Full Text] [Related]
27. Dynamic shifts in occupancy by TAL1 are guided by GATA factors and drive large-scale reprogramming of gene expression during hematopoiesis.
Wu W; Morrissey CS; Keller CA; Mishra T; Pimkin M; Blobel GA; Weiss MJ; Hardison RC
Genome Res; 2014 Dec; 24(12):1945-62. PubMed ID: 25319994
[TBL] [Abstract][Full Text] [Related]
28. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
[TBL] [Abstract][Full Text] [Related]
29. PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation.
Kolodziej S; Kuvardina ON; Oellerich T; Herglotz J; Backert I; Kohrs N; Buscató El; Wittmann SK; Salinas-Riester G; Bonig H; Karas M; Serve H; Proschak E; Lausen J
Nat Commun; 2014 May; 5():3995. PubMed ID: 24874575
[TBL] [Abstract][Full Text] [Related]
30. T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.
Rogers H; Wang L; Yu X; Alnaeeli M; Cui K; Zhao K; Bieker JJ; Prchal J; Huang S; Weksler B; Noguchi CT
J Biol Chem; 2012 Oct; 287(44):36720-31. PubMed ID: 22982397
[TBL] [Abstract][Full Text] [Related]
31. Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression.
Ferreira R; Spensberger D; Silber Y; Dimond A; Li J; Green AR; Göttgens B
Mol Cell Biol; 2013 Mar; 33(6):1254-66. PubMed ID: 23319051
[TBL] [Abstract][Full Text] [Related]
32. Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation.
Condorelli G; Vitelli L; Valtieri M; Marta I; Montesoro E; Lulli V; Baer R; Peschle C
Blood; 1995 Jul; 86(1):164-75. PubMed ID: 7540882
[TBL] [Abstract][Full Text] [Related]
33. TGF-beta induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylation.
Terme JM; Lhermitte L; Asnafi V; Jalinot P
Blood; 2009 Jun; 113(26):6695-8. PubMed ID: 19406989
[TBL] [Abstract][Full Text] [Related]
34. SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells.
Real PJ; Ligero G; Ayllon V; Ramos-Mejia V; Bueno C; Gutierrez-Aranda I; Navarro-Montero O; Lako M; Menendez P
Mol Ther; 2012 Jul; 20(7):1443-53. PubMed ID: 22491213
[TBL] [Abstract][Full Text] [Related]
35. FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.
Fleskens V; Mokry M; van der Leun AM; Huppelschoten S; Pals CE; Peeters J; Coenen S; Cardoso BA; Barata JT; van Loosdregt J; Coffer PJ
Oncogene; 2016 Aug; 35(31):4141-8. PubMed ID: 26686090
[TBL] [Abstract][Full Text] [Related]
36. Cross talk between expression of the human T-cell leukemia virus type 1 Tax transactivator and the oncogenic bHLH transcription factor TAL1.
Terme JM; Wencker M; Favre-Bonvin A; Bex F; Gazzolo L; Duc Dodon M; Jalinot P
J Virol; 2008 Aug; 82(16):7913-22. PubMed ID: 18495761
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation by mitogen-activated protein kinase mediates the hypoxia-induced turnover of the TAL1/SCL transcription factor in endothelial cells.
Tang T; Arbiser JL; Brandt SJ
J Biol Chem; 2002 May; 277(21):18365-72. PubMed ID: 11904294
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells.
Kassouf MT; Hughes JR; Taylor S; McGowan SJ; Soneji S; Green AL; Vyas P; Porcher C
Genome Res; 2010 Aug; 20(8):1064-83. PubMed ID: 20566737
[TBL] [Abstract][Full Text] [Related]
39. Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia.
Tan TK; Zhang C; Sanda T
Int J Hematol; 2019 Jan; 109(1):5-17. PubMed ID: 30145780
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
